^○Hiroshi Aino¹, Kenji Baba¹, Hidetoshi Shibahara², Sachie Inoue², Ichiro Naoi¹ (1.Sumitomo Pharma Co., Ltd., Japan, 2.CRECON Medical Assessment Inc.)

^○Ryuichi Koizumi^1,2, Kazuhiro Takeda¹, Shusei Arafuka¹, Hideyuki Moriyoshi¹, Hiroyuki Yabata¹, Takashi Ando¹, Akio Akagi¹, Yuichi Riku¹, Hiroaki Miyahara¹, Jun Sone¹, Fumiaki Tanaka², Mari Yoshida¹, Yasushi Iwasaki¹ (1.Aichi Medical University, Institute of Neuropathology, Japan, 2.Yokohama City University, Department of Neurology and Stroke Medicine, Japan)

^○Kanako Menjo, Fukiko Morii, Takashi Kasai, Takuma Omichi, Makiko Shinomoto, Yuzo Fujino, Toshiki Mizuno (University Hospital Kyoto Prefectural University of Medicine, Japan)

^○Mayu Sugata^1,2, Hiroshi Kataoka², Kazuma Sugie² (1.Nara Prefecture General Medical Center, Neurology, Japan, 2.Nara medical university, Neurology, Japan)

^○Toru Nakagami, Syunya Nakane, Yosuke Fujisawa, Hiroshi Nagayama, Kazumi Kimura (Department of Neurological Science, Graduate School of Medicine, Nippon Medical School, Japan)

^○Fumiko Nakamoto, Tomohiko Kimura, Satoshi Kobayashi, Yuki Nagasako, Yusuke Sugiyama, Taro Bannai, Minako Yamada, Tomonari Seki, Yasushi Shiio (Tokyo Teishin Hospital Department of Neuroloy, Japan)